Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
free free
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Polycystic kidney diseases: from molecular discoveries to targeted therapeutic strategies Ibraghimov-Beskrovnaya O; Bukanov NCell Mol Life Sci 2008[Feb]; 65 (4): 605-19Polycystic kidney diseases (PKDs) represent a large group of progressive renal disorders characterized by the development of renal cysts leading to end-stage renal disease. Enormous strides have been made in understanding the pathogenesis of PKDs and the development of new therapies. Studies of autosomal dominant and recessive polycystic kidney diseases converge on molecular mechanisms of cystogenesis, including ciliary abnormalities and intracellular calcium dysregulation, ultimately leading to increased proliferation, apoptosis and dedifferentiation. Here we review the pathobiology of PKD, highlighting recent progress in elucidating common molecular pathways of cystogenesis. We discuss available models and challenges for therapeutic discovery as well as summarize the results from preclinical experimental treatments targeting key disease-specific pathways.|Cell Adhesion[MESH]|Cell Cycle/genetics[MESH]|Humans[MESH]|Kidney Failure, Chronic/epidemiology[MESH]|Models, Molecular[MESH]|Mutation[MESH]|Polycystic Kidney Diseases/complications/*genetics/*therapy[MESH]|Polycystic Kidney, Autosomal Dominant/*genetics/therapy[MESH]|Protein Conformation[MESH]|Receptors, Cell Surface/chemistry/genetics[MESH]|TRPP Cation Channels/chemistry[MESH] |